Ethinamate: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Ethinamate == | |||
[[File:Ethinamate_synthesis.png|thumb|right|Synthesis of Ethinamate]] | |||
'''Ethinamate''' is a [[sedative]] and [[hypnotic]] medication that was once commonly used for the short-term treatment of [[insomnia]]. It belongs to the class of [[carbamate]] derivatives and acts as a central nervous system [[depressant]]. | |||
== | == Pharmacology == | ||
Ethinamate works by enhancing the effects of the inhibitory neurotransmitter [[gamma-aminobutyric acid]] (GABA) in the brain, which leads to a calming effect on the central nervous system. This action helps to induce sleep and reduce anxiety in patients suffering from insomnia or other sleep disorders. | |||
Ethinamate | |||
== | == Medical Uses == | ||
Ethinamate was primarily prescribed for the short-term management of insomnia. Due to its potential for [[tolerance]] and [[dependence]], it was generally recommended for use only when other treatments were ineffective or inappropriate. | |||
== | == Side Effects == | ||
== | Common side effects of ethinamate include [[drowsiness]], [[dizziness]], and [[headache]]. More serious side effects can include [[allergic reactions]], [[respiratory depression]], and [[confusion]]. Long-term use can lead to [[dependence]] and [[withdrawal symptoms]] upon discontinuation. | ||
* [[Sedative | |||
== Synthesis == | |||
The synthesis of ethinamate involves the reaction of [[ethyl chloroformate]] with [[ethanolamine]] to form the corresponding carbamate. This process is depicted in the image to the right. | |||
== History == | |||
Ethinamate was first introduced in the 1950s and was widely used as a hypnotic agent. However, due to the development of newer and safer [[hypnotic drugs]], its use has declined significantly. | |||
== Related Pages == | |||
* [[Sedative]] | |||
* [[Hypnotic]] | |||
* [[Carbamate]] | |||
* [[Insomnia]] | * [[Insomnia]] | ||
* [[ | * [[Gamma-aminobutyric acid]] | ||
[[Category:Sedatives]] | [[Category:Sedatives]] | ||
[[Category:Hypnotics]] | [[Category:Hypnotics]] | ||
[[Category: | [[Category:Carbamates]] | ||
Latest revision as of 11:01, 15 February 2025
Ethinamate[edit]

Ethinamate is a sedative and hypnotic medication that was once commonly used for the short-term treatment of insomnia. It belongs to the class of carbamate derivatives and acts as a central nervous system depressant.
Pharmacology[edit]
Ethinamate works by enhancing the effects of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain, which leads to a calming effect on the central nervous system. This action helps to induce sleep and reduce anxiety in patients suffering from insomnia or other sleep disorders.
Medical Uses[edit]
Ethinamate was primarily prescribed for the short-term management of insomnia. Due to its potential for tolerance and dependence, it was generally recommended for use only when other treatments were ineffective or inappropriate.
Side Effects[edit]
Common side effects of ethinamate include drowsiness, dizziness, and headache. More serious side effects can include allergic reactions, respiratory depression, and confusion. Long-term use can lead to dependence and withdrawal symptoms upon discontinuation.
Synthesis[edit]
The synthesis of ethinamate involves the reaction of ethyl chloroformate with ethanolamine to form the corresponding carbamate. This process is depicted in the image to the right.
History[edit]
Ethinamate was first introduced in the 1950s and was widely used as a hypnotic agent. However, due to the development of newer and safer hypnotic drugs, its use has declined significantly.